N/A
Completed N=102
A Brief Community Linkage Intervention for Dually Diagnosed Individuals
Source: ClinicalTrials.gov NCT00137267 ↗Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcomePrimary: Treatment Engagement — 4.2; 1.4; 7.2; 1.5 number of treatment sessions attended — p=<0.001
Summary
Surveys suggest that up to 80% of veterans with a persistent mental illness have a co-occurring substance use disorder. Substance abuse among this population is problematic and often results in poor engagement in treatment and thus, frequent hospitalizations and an unstable illness course. Regarding treatment engagement, data from a VA New Jersey facility indicated that 50% of those veterans discharged from the acute psychiatric hospital unit to outpatient care did not attend their initial screening appointment and another 30% dropped out within six weeks. To assist with the transition from inpatient to outpatient care, we previously developed an eight-week augmentation intervention entitled, Time-Limited Case Management (TLC). TLC integrates evidence-based interventions of 1) Dual Recovery Therapy; 2) Critical Time Intervention Case Management along with 3) Peer Support with the goal of assisting individuals with the transition from inpatient to outpatient care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Treatment Engagement |
4.2; 1.4; 7.2; 1.5 | <0.001 sig |
| SECONDARY Number of Days Engaged |
37.3; 28.9 | 0.152 |
Eligibility Criteria
Inclusion Criteria
- Male and female patients over 18 years old.
- Patients who have a substance abuse disorder and a diagnosis of schizophrenia, schizoaffective disorder, or bipolar I disorder.
- Patients seeking outpatient treatment for the above disorders from the VA.
- Physically mobile
- Agree to take public transportation if they do not have other private sources.
Exclusion Criteria
- Patients who only have either a mental health problem, or a substance abuse problem, but not both.
- Patients who do not have a residence where they can stay upon discharge from the hospital.
- Patients who are not sufficiently medically or psychiatrically stable to participate in residential or outpatient treatment. Those patients could be re-evaluated for the study once stabilized.
- Patients exclusively engaged in methadone maintenance programs.
- Patients who represent a serious suicide risk.
Data sourced from ClinicalTrials.gov (NCT00137267). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.